Patient Survey on Lipodystrophy
Patient Survey on Lipodystrophy Read More »
Uncategorized
Tenofovir Dosing for patients with kidney dysfunction
I have seen some confusion about Tenofovir (Viread, which is in Truvada and Atripla) dosing in those with kidney problems in my pozhealth at yahoogroups.com list, so I am posting this information. So far, most of the problems with tenofovir and kidney function have been reported in treatment experienced patients on boosted protease inhibitors, african
Tenofovir Dosing for patients with kidney dysfunction Read More »
37.5 percent of US patients skip AIDS/HIV treatment due to side effects.
FROM: https://pharmexec.findpharma.com/pharmexec/article/articleDetail.jsp?id=534038 A new study released at the 17th International AIDS Conference in Mexico City on Monday detailed the disconcerting fact that 37.5 percent of US interviewees skip AIDS/HIV treatment due to side effects. AIDS Treatment for Life (ATLIS) polled approximately 3,000 HIV-positive patients from 18 countries to get a better understanding of their treatment
37.5 percent of US patients skip AIDS/HIV treatment due to side effects. Read More »
S-Adenosyl-L-Methionine (SAMe) for Treatment of Depression, Osteoarthritis, and Liver Disease
I am convinced this supplement works for depression and fatigue. I have taken 400 mg twice a day and can definitely feel a difference the first day. Something else that I have noticed is that my hairy leukoplakia goes away within days. It can also decrease liver enzymes. However, it is contraindicated for those with
Is Exercise Important for People with HIV?
We need more programs around the Unites States and the world that provide supervised exercise programs for people with HIV! Association between Exercise and HIV Disease Progression in a Cohort of Homosexual Men . Annals of Epidemiology , Volume 9 , Issue 2 , Pages 127 – 131 T . Mustafa Having exercised was associated
Is Exercise Important for People with HIV? Read More »
The Coming Crisis in HIV Drug Development
Excellent article by Paul Dalton Project Inform The Coming Crisis in HIV Drug DevelopmentBy Paul Dalton June 16, 2008 The last few years have seen tremendous progress in treating people with advanced and drug-resistant HIV. Four powerful drugs became available that either overcame drug resistance (Prezista [darunavir, TMC-114], Intelence [etravirine, TMC-125]) or were from entirely
The Coming Crisis in HIV Drug Development Read More »
My Column at TheBody.com
TheBody.com is one of the most visited web sites in the world of HIV. It has many experts that answer health questions for free. I am honored to be part of this web site. Here is the link to my columnhttps://www.thebody.com/Forums/AIDS/Nutrition/index.html
My Column at TheBody.com Read More »
Mortality Down 94% in HIV Among Diagnosed
NATAP https://natap.org/_______________________________________________ Changes in the Risk of Death After HIV Seroconversion Compared With Mortality in the General PopulationKrishnan Bhaskaran, MSc; Osamah Hamouda, MD; Mette Sannes, MLabTech;Faroudy Boufassa, MD; Anne M. Johnson, MD; Paul C. Lambert, PhD; Kholoud Porter, PhD; for the CASCADE Collaboration JAMA. July 2, 2008;300(1):51-59. “…..To our knowledge, no study to date has
Mortality Down 94% in HIV Among Diagnosed Read More »